PortLens compared · 1 of 5

Is there a free alternative to Morningstar X-Ray?

For the look-through, yes.

Add the funds and stocks you hold.

Free, no account, up to 5 holdings.

Example: 10 VOO, 5 VTI and 2 NVDA shares. Free scan, Oct 16, 2026; fund holdings as of Jun 30, 2026.

TRUE EXPOSURE

DIRECT + INSIDE FUNDS

Your 3 positions put 38% of your money in 10 holdings. NVDA alone is 12% of your money. You hold it directly and through 2 of your funds.

38%
NVDA12%
≈40of 3495

Published by PortLens, one of the tools compared.

PortLens Team · Morningstar X-Ray details checked Oct 18, 2026

For the look-through half of X-Ray, yes: PortLens opens your funds up to the companies inside them, adds up where they pile into the same names and reports a weighted fund cost, free and with no account for up to 5 holdings. For the rest of the report, no. X-Ray is a feature of the paid Morningstar Investor subscription, alongside account linking and asset allocation. PortLens has no account linking and covers asset allocation only in part: it names the bonds and cash inside your funds by type, with no fixed-income analysis.

What does each one measure?

Read against the PortLens capability inventory on one side and Morningstar's own product pages on the other, Oct 18, 2026.
PortLensMorningstar X-Ray
What does it cost to get an answer?Free; no account is needed for a scan of up to 5 holdings, and a longer list takes a free account.Sold inside Morningstar Investor: $249 a year or $34.95 a month, after a seven-day free trial.
How do holdings get in?Typed in, or with a free account read from a screenshot of your broker's holdings screen; a scan without an account takes up to 5 typed holdings.Linked accounts, or entered by hand.
Does it look through funds to the companies inside?Yes, free on every scan.Yes. X-Ray reports overall asset allocation, sector weightings and fees; Stock Intersection surfaces concentrated positions.
Does it report a weighted expense ratio?Yes, free, with the number of holdings it covers and the ones it excluded named.Yes. Fees are one of the things Morningstar lists X-Ray as laying out.
Does it cover bonds, cash and an asset-allocation mix?Partly. It shows how much of your money sits in bonds and cash inside your funds, named by type, but offers no fixed-income analysis such as yield, duration or credit quality.Yes. Overall asset allocation is the first thing Morningstar names.

Is Morningstar X-Ray free?

No. X-Ray is part of Morningstar Investor, which Morningstar prices at $249 a year or $34.95 a month after a seven-day free trial, as of Oct 18, 2026. The free Instant X-Ray is gone: Morningstar's notice of April 15, 2025, linked under Sources, retired X-Ray and Instant X-Ray on its Europe, Canada and Asia sites, and on Nov 4, 2026 the old US address led to the Morningstar Investor sales page. What happened to Instant X-Ray covers the rest.

What is Morningstar X-Ray?

X-Ray is Morningstar's portfolio look-through report. Morningstar's own product page describes it as laying out a portfolio's overall asset allocation, sector weightings and fees, and describes a companion tool, Stock Intersection, as uncovering concentrated positions so you can see how much any one security can affect you. Both sit inside Morningstar Investor, which that page prices at $249 a year or $34.95 a month after a seven-day free trial, and which lets you either link accounts or enter holdings by hand. Those details were read from Morningstar's own pages on Oct 18, 2026; a subscription price is the kind of fact that moves, so check it there rather than here.

What does PortLens do?

When a SEC N-PORT filing resolves, PortLens explodes the fund into the equity positions that source lists, multiplies each company's weight by the fund's weight in the portfolio, and adds up exposure to the same company across the resolved funds and directly held shares. Three funds that look different on a statement come back as the single concentrated position they are. On top of that sit effective holdings, top-ten concentration, a diversification score, portfolio beta against the S&P 500 total return, and a weighted expense ratio, all free. A signed-out scan supports up to 5 holdings, and every figure is documented on the methodology page.

PortLens sets no per-fund ceiling of its own on how many constituents it reads from a filing. It opens up a fund's shares company by company and names its bonds, cash and derivatives by type, with no fixed-income analysis; nor does every fund always resolve (most often international listings, and certain UCITS funds that file no US holdings report). An unresolved fund contributes no underlying companies. Below roughly three quarters reported look-through coverage, the concentration figures understate what is really there.

A tested case: how much of a three-position portfolio sits in the same companies?

38.5% of it sits in ten companies, and one of them, NVIDIA, is 11.6% of the whole. That is what the free signed-out PortLens scan returned on Oct 16, 2026 for a fictional portfolio of 10 shares of VOO, 5 shares of VTI and 2 shares of NVDA: an S&P 500 fund bought first, a total-market fund added later for the smaller companies the first one leaves out, and two shares of one chipmaker bought on their own. The run is published here with its inputs and its dates so the comparison above rests on a case you can repeat, and every figure in it is computed as the methodology page describes.

Share counts were the only input. The scan takes a ticker and a share count per row and derives the weights itself; it does not accept percentages or dollar amounts, and a signed-out scan shows no prices or values, so none appear here. From 10, 5 and 2 shares it derived VOO 75.3%, VTI 20.1% and NVDA 4.6% of the portfolio at that day's closes. Both funds were read through their own SEC N-PORT filings, holdings as of Jun 30, 2026; nothing was estimated from another fund's list, look-through coverage was 100% of the input value, and no holding was excluded. The figures describe those filings at those weights on that day, and a newer filing or a price move changes every one of them.

The ten largest underlying companies in the fixture, free signed-out scan, Oct 16, 2026; fund holdings as of Jun 30, 2026. Weights are shares of the whole portfolio, and every one of the ten sits inside both funds.
CompanyTickerShare of portfolioHeld directly
NVIDIA CorpNVDA11.6%Yes
Apple IncAAPL6.1%No
Microsoft CorpMSFT4.0%No
Amazon IncAMZN3.4%No
Alphabet IncGOOGL3.0%No
Broadcom IncAVGO2.6%No
Alphabet IncGOOG2.4%No
Micron Technology IncMU1.9%No
Meta Platforms IncMETA1.8%No
Tesla IncTSLA1.7%No
3,485 more companies61.3%

Three line items on a statement are 3,495 companies underneath, behaving like about 40 equally weighted ones (effective holdings 39.6), with the ten largest holding 38.5% of the money and the other 3,485 companies the remaining 61.3%, as of Oct 16, 2026. Alphabet appears twice, as GOOGL and GOOG, because the filings list the two share classes as separate securities and PortLens keeps them apart. The same run scored the portfolio 6.6 out of 10, a blend of the design weights the methodology page sets out, and put its weighted fund cost at 0.03% a year with all three holdings covered: VOO 0.03%, VTI 0.03%, and NVDA a share that carries no fund fee.

How does the direct NVDA position combine with the funds? Multiply, then add: each fund's weight in the portfolio times NVIDIA's weight inside that fund, plus the direct position. NVIDIA's weight inside each fund comes from the VOO vs VTI pair page, on the same Jun 30, 2026 filings.

NVIDIA's three routes into the fixture, Oct 16, 2026. Position weights are the scan's; the weight inside each fund is the fund's own filing as of Jun 30, 2026.
RoutePosition weightNVIDIA inside the fundContribution
Held directly (2 shares)4.6%4.6%
Via VOO (10 shares)75.3%7.5%5.7%
Via VTI (5 shares)20.1%6.4%1.3%
Total11.6%

The two index funds hand this portfolio more NVIDIA than the deliberate purchase does: 7.0 points through the funds against 4.6 bought on purpose. A pair comparison of VOO and VTI shows that both funds hold NVIDIA; only a whole-portfolio look-through adds the direct shares and both funds into one figure.

The same arithmetic on a hypothetical allocation, labeled as one because the scan did not produce it: a portfolio that was 60% VOO, 30% VTI and 10% NVDA by value would hold NVIDIA at 10% + 60% × 7.5% + 30% × 6.4% = 16.4% on the same Jun 30, 2026 fund weights. Today's scan does not accept an allocation in percentages or dollars, so reproducing that split means entering share counts that come to those weights at current prices.

This is the case the look-through handles best, two large US index funds with current filings, and the figures would look worse with a fund it cannot open: that fund's weight would show up as uncovered, pulling the coverage figure down and leaving the concentration figures understated.

Each tool's status for this question on Oct 16, 2026. Tested: run on the fixture that day. Documented only: read from the vendor's own pages and not run. Unavailable: closed to a signed-out visitor, so not run.
PortLens free scanTested Oct 16, 2026The whole question. It took the three typed rows, opened both funds and returned the combined list above with its coverage and the fund dates behind it.
ETF Research Center Fund OverlapTested Oct 16, 2026, VOO against VTIThe pair only. Run signed out the same day with VOO and VTI, it returned an overlap percentage, a count of overlapping holdings, each fund's holdings count with the share of it also in the other fund, the five largest shared holdings with each fund's weight (the complete list needs its free Basic membership) and each fund's overweights, with no holdings date on the result. It has no row for the two direct NVDA shares or for a third fund, so it cannot say what NVIDIA adds up to across everything owned, and its own page points to Portfolio Builder for more than two funds. Its computed figures are not reproduced here; its pages are linked from the ETF Research Center comparison.
ETF Research Center Portfolio BuilderUnavailable, not runThe route Fund Overlap gives for more than two funds. Its subscriptions page lists it under the paid tiers, so it was closed to this signed-out run and nothing was bought to test it.
Morningstar Stock IntersectionDocumented only, not runInside paid Morningstar Investor. Morningstar's own product page, read Oct 18, 2026 and linked under Sources, says it “uncovers concentrated positions in your portfolio so you know how much any given security can impact you”, for linked or hand-entered holdings. That is this case's question; the subscription was not bought for this page, so no output is reported.
Portfolio VisualizerDocumented only, not runIts own pricing page lists backtesting, Monte Carlo simulation and factor regression on a login-free tier and names no fund look-through or holdings-overlap tool. Its job is what a stated allocation would have returned; this case asks what the allocation holds. Read from its pages Oct 18, 2026 and linked from the Portfolio Visualizer comparison.

To run your own, use the look-through at the top of this page or the full free scan: type each ticker and its share count; up to 5 rows need no account. Nothing loads this fixture into your own rows, and the figures above are one day's snapshot, so what comes back describes your own rows at that day's closes and filings.

Free Morningstar X-Ray alternatives, compared

Seven tools on the shortlist open funds up to the companies inside them, each on different terms. My Financial Freedom Tracker, overlap.tools and PortLens do it across a whole portfolio, free and with no account; Guardfolio does it free from an uploaded file; AllInvestView compares up to five ETFs and runs its Portfolio X-Ray on the holdings in its tracker; Sharesight's Exposure Report needs an account; and ETF Research Center's Fund Overlap takes two funds at a time. Each covers part of what X-Ray does, and the table sets out which part and what each one does not do.

The rest of the shortlist is left out on one criterion, fixed before any row was read: their own pages describe no way to open a fund up to the companies inside it. That leaves out Empower, Portfolio Performance and Portfolio Visualizer, which are compared for their own jobs in free portfolio analysis tools compared by task.

Each tool's row is read from the pages linked under its name, on the date shown; the PortLens row is read from its own capability inventory. Rows are documented from those pages rather than tested, apart from the PortLens scan and ETF Research Center's Fund Overlap in the tested case above. Alphabetical, and nothing here is ranked.
AllInvestViewTracker and plans · ETF Overlap toolChecked Oct 18, 2026Fund look-throughIts ETF Overlap tool compares up to five ETFs, or an ETF and a stock; its Portfolio X-Ray does the same with the holdings in its tracker.Free accessA free plan with one portfolio and ten holdings; paid plans from $6.99 a month, each with a 14-day trial.Holdings inBroker sync on paid plans, CSV import from any broker, or entered by hand.What it does not doNo broker sync on the free plan.
ETF Research CenterFund Overlap · SubscriptionsChecked Oct 18, 2026Fund look-throughFund Overlap compares two equity ETFs; overlap across more than two goes to Portfolio Builder, on the paid tiers.Free accessFund Overlap with no account shows the top five shared holdings; a free Basic membership shows the full list.Holdings inTwo ETF tickers in Fund Overlap; all-ETF portfolios in Portfolio Builder.What it does not doFund Overlap takes no third fund and no directly held stock.
GuardfolioMonitoring and pricing · Free risk report · ETF overlap checkerChecked Oct 18, 2026Fund look-throughA free report checks ETFs and directly held stocks together from an uploaded file; connected accounts get portfolio-weighted overlap on its paid plans.Free accessThe upload report, and a two-fund checker covering 22 US-listed funds, with no brokerage login; monitoring after a seven-day trial.Holdings inRead-only broker connections, or a CSV, Excel, PDF or screenshot upload for the free report.What it does not doNo permanent free monitoring plan, and its free report may miss holdings not in the file.
My Financial Freedom TrackerPortfolio analysis tool · PricingChecked Oct 18, 2026Fund look-throughThe free tool opens every fund at once, to each fund’s largest disclosed positions, and reports how much it could see.Free accessThe analysis tool, with no login, for up to 150 holdings; the app is €4.99 a month, €49.90 a year or €299 once.Holdings inTickers and share counts, or an import from a broker.What it does not doNo drift monitoring or alerts, and funds sold only by ISIN cannot be looked up.
overlap.toolsAnalyzer and ETF CompareChecked Oct 18, 2026Fund look-throughIts Analyzer looks through a whole portfolio; ETF Compare checks two funds.Free accessEverything on the site, with no account; holdings stay in the browser.Holdings inTickers with dollar or percentage amounts, typed or pasted from a broker list.What it does not doIts page calls the fund data approximate sample data in this preview, covering 60+ of the most commonly held stocks and funds without a data key.
PortLensFree scanChecked Oct 18, 2026Fund look-throughYes, across every fund it can open and every directly held share.Free accessA scan of up to 5 holdings with no account. A free account adds a longer list, sector exposure, Value at Risk, maximum drawdown and Monte Carlo. Pro, waitlist only, adds the geographic breakdown.Holdings inTickers and share counts, typed in or read from a screenshot of your broker's holdings screen.What it does not doNo backtest, no performance, dividend or tax tracking, and no advice. Factor regression is planned for Pro.
SharesightPlans and pricing · Exposure ReportChecked Oct 18, 2026Fund look-throughIts Exposure Report shows the top 50 to 500 holdings inside ETFs listed in Australia, Canada, New Zealand, the UK, the US and the EU, and flags overlap.Free accessAn account; the free plan covers one portfolio and ten holdings, counting closed ones.Holdings inBroker integrations and trade confirmation email imports.What it does not doIts Exposure Report cannot look through managed funds identified by APIR code or by GB, IE or LU ISIN.

What does neither of them do?

Neither tool places an order, holds money, or knows anything about your circumstances. PortLens in particular collects no objectives, horizon or loss capacity, runs the same models for everybody, and is not an investment adviser, which is why nothing it outputs is a recommendation, and why it publishes no tax content of any kind. It also holds no real-time data.

If the specific thing you came for is two funds side by side rather than a whole portfolio, the ETF overlap checker answers that directly, and VOO vs VTI is a worked example with its own numbers and as-of date. For what a look-through report contains and what happened to the free Instant X-Ray, see what a portfolio X-Ray shows.

Where Morningstar X-Ray does more than PortLens

Morningstar Investor is a broader product and reports several things PortLens has no answer to at all. Its own description of X-Ray leads with overall asset allocation (the stock, bond and cash mix of a whole portfolio), and PortLens covers only part of that: it names the bonds and cash inside your funds by type, with no fixed-income analysis. Morningstar also links accounts, so holdings arrive and stay current on their own, where PortLens holdings are entered afresh each time. And a subscription carries Morningstar's ratings and research, which is a different product category rather than a feature PortLens has a smaller version of.

If what you want is the whole X-Ray report, PortLens is not a replacement for it. If what you want is the look-through (which companies the available sources identify across your funds, and how much they add up to), that is the part PortLens does for free.

How do I look through my own portfolio?

Type in tickers and share counts; PortLens calculates the position weights. It runs free and without an account for up to 5 holdings; a longer list, or reading your holdings from a screenshot, takes a free account. A scan shows how much of your money it could open up into companies; a fund counts as opened even when its published list is partial. The fund-cost figure names any fund with no published fee rather than counting it as free. What each figure means and how it is computed is on the methodology page. All investing involves risk, including possible loss of principal, and past performance does not guarantee future results.

Key takeaways

  • X-Ray is not gone; it is part of a paid subscription, priced by Morningstar at $249 a year or $34.95 a month with a seven-day trial as of Oct 18, 2026.
  • The overlapping capability is look-through: both explode funds into the companies inside them, and both report a weighted fund cost.
  • PortLens does that half free and without an account for up to 5 holdings. Its look-through coverage figure is an upper bound on what it saw through, not a measure of completeness.
  • Morningstar does more: asset allocation across stocks, bonds and cash, account linking, and its own ratings and research. PortLens names the bonds and cash inside your funds but offers no fixed-income analysis, links no accounts and publishes no ratings.
  • The tested case on this page, 10 VOO, 5 VTI and 2 NVDA shares scanned Oct 16, 2026 on holdings as of Jun 30, 2026, turns a 4.6% direct NVIDIA position into 11.6% of the portfolio once both funds are opened.

This article is for information and education only and is not investment advice. Analytics referenced are computed as described in our methodology; see our disclosures.